NICI Quick Take



Isracann Biosciences, Inc. is an Israel-based medical cannabis company.  Through its partnership with Yamko, a global, agriculture construction company, it’s able to build its facility. It’s facility will be a 230,000 square feet cultivation facility in Israel. It’s currently in phase 1 of 2. The first phase will be scaled to be 115,000 sq. ft. with an annual capacity of 11,600 kg of cannabis. Phase 2, the final phase is set to be complete in Q3 of 2019 with an approximation of 23,000 kg of cannabis production per year. The company estimates it will go public before the end of 2019.

IPO Details

Valuation $65.0M
Total Raised $10.1M
NICI Subsector Cultivator, Processor